“4+7”带量采购政策对某院胰岛素类药物的使用情况分析

Utilization Analysis of“4+7”Volume Procurement Policy on Insulin Drugs in a Hospital

目的对比“4+7”带量采购前后门诊胰岛素使用相关数据,分析带量采购政策对胰岛素使用的影响以及经济效应,为完善政策提供数据支撑。方法通过数字化医院信息管理系统(Hospital Information System,HIS)调取带量采购政策实施前后同期门诊胰岛素的价格、使用量、销售金额、用药频度(Dynamic Delegation Discovery System,DDDs)、日均费用(Defined Daily Cost,DDC)等数据,进行统计分析整理出降幅、估计节省费用等评价指标。结果所有的胰岛素价格降幅为9.36%至71.81%,使用量下降9.55%,销售金额降低135.5万余元,不同胰岛素之间DDDs差距缩小,估计半年节省药费94.79万余元。结论胰岛素带量采购后,中标胰岛素联动非中标胰岛素降价,使日均费用大幅下降,减轻了糖尿病患者与医保的负担。

OBJECTIVE Comparing the data of insulin use in the outpatient department before and after the“4+7”volume procurement,this paper analyzes the impact of the volume procurement policy on insulin use and its economic effects.METHODS Through the HIS,the price,usage,sales amount,DDDs and DDC of insulin in outpatient department during the same period before and after the implementation of volume procurement policy were obtained,and the evaluation indexes such as decrease amplitude and estimated cost were analyzed.RESULTS The price of all insulin decreased by 9.36% to 71.81%,the usage decreased by 9.55%,the sales value decreased by 1.355 million yuan,the gap between different insulin DDDs narrowed,and it was estimated that the drug cost saved by 947,900 yuan in half a year.CONCLUSION After the volume procurement of insulin,the bidding insulin linked to the price reduction of the non-bidding insulin,as a result,average daily cost was drastically reduced,the burden of diabetics and health insurance is taken off.